首页 > 最新文献

The Lancet regional health. Southeast Asia最新文献

英文 中文
Invasive mould infections of the central nervous system in the Indian population: a cohort study (2004–2025) 印度人群中枢神经系统侵袭性霉菌感染:一项队列研究(2004-2025)
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-03-04 DOI: 10.1016/j.lansea.2026.100736
Harsimran Kaur , Shivaprakash M. Rudramurthy , Rimjhim Kanaujia , Haseen Ahmad , Pravin Salunke , Deepak Bansal , Kirti Gupta , Debajyoti Chatterjee , Chirag Kamal Ahuja , Aastha Takkar Kapila , Manish Modi , Sandeep Mohindra , Rajesh Chhabra , Madhivanan Karthigeyan , Harpreet Singh , Apinderpreet Singh , Ashish Agarwal , Sanjay Verma , Sunil Kumar Gupta , Sanjay Jain , Arunaloke Chakrabarti

Background

Central nervous system (CNS) invasive mould infection (IMI) is a rare but life-threatening condition. Limited large-scale studies hinder the understanding of its clinical characteristics and optimal management strategies.

Methods

This was a cohort study. We reviewed confirmed patients of CNS IMI (January 2004–March 2025) by microbiological (direct microscopy and/or culture) and/or histopathological evidence at our tertiary care hospital. Clinical, demographic and mycological characteristics were analysed and compared.

Findings

Among 1321 brain abscess/biopsy samples, 127 patients (9.6%) were of fungal origin (adults, 100; paediatrics, 27). The median age was 30 (IQR: 27) years, with male predominance (71.7%). Adults were significantly infected by melanized fungi (p = 0.003). Seventy-four percent of patients had no identifiable underlying immunocompromising condition. The median duration of symptoms was 15 days (IQR: 23 days), including headache (61.4%) and seizures (50.4%). Frequency of fever was significantly higher in infection by melanized fungi (p = 0.02). Frontal lobe involvement was common in paediatric age (OR 0.379, 95% CI 0.141–1.019; p = 0.05). Aspergillus spp. (56.3%) and Cladophialophora bantiana (21.36%) were the predominant pathogens. Deniquelata barringtoniae was reported as a human pathogen. Voriconazole (61.4%) and liposomal amphotericin B (28.3%) were the primary antifungals used. Surgical intervention was performed in all patients. Partial excision (66.7% vs 38.0%, OR 0.306, 95% CI 0.125–0.751; p = 0.01) and use of liposomal amphotericin B (55.6% vs 21%, OR 0.213, 95% CI 0.087–0.522 p = 0.001) were common in paediatric patients. The overall mortality was 30.7%, complete excision was significantly more frequent among survivors than non-survivors (67.0% vs 30.8%; OR 0.218, 95% CI 0.097–0.492; p = 0.001). Lack of headache (p = 0.044) and partial excision surgery (p = 0.001) were independently associated with poor outcome.

Interpretation

We describe a compendium of CNS IMI in patients from India, highlighting distinct clinical patterns and treatment outcomes across age groups and fungal types. This warrants investigation of host and pathogen-related factors in the country.

Funding

Funding included Department of Science and Technology-Science and Engineering Research Board (DST-SERB), New Delhi, India and Indian Council of Medical Research (ICMR), New Delhi, India.
中枢神经系统(CNS)侵袭性霉菌感染(IMI)是一种罕见但危及生命的疾病。有限的大规模研究阻碍了对其临床特征和最佳管理策略的理解。方法本研究为队列研究。我们通过微生物学(直接显微镜和/或培养)和/或组织病理学证据回顾了我们三级保健医院确诊的CNS IMI患者(2004年1月- 2025年3月)。对临床、人口学和真菌学特征进行分析和比较。在1321例脑脓肿/活检样本中,127例(9.6%)为真菌来源(成人100例,儿科27例)。中位年龄30岁(IQR: 27)岁,男性占71.7%。成人感染黑化真菌显著(p = 0.003)。74%的患者没有可识别的潜在免疫损害状况。症状持续时间中位数为15天(IQR: 23天),包括头痛(61.4%)和癫痫发作(50.4%)。黑化真菌感染组发热频率显著高于对照组(p = 0.02)。额叶受累在儿童中很常见(OR 0.379, 95% CI 0.141-1.019; p = 0.05)。主要病原菌为曲霉(56.3%)和板栗Cladophialophora bantiana(21.36%)。barringtonideniquelata是一种人类病原体。伏立康唑(61.4%)和两性霉素B脂质体(28.3%)是主要的抗真菌药物。所有患者均行手术治疗。部分切除(66.7% vs 38.0%, OR 0.306, 95% CI 0.125-0.751; p = 0.01)和使用两性霉素B脂质体(55.6% vs 21%, OR 0.213, 95% CI 0.087-0.522 p = 0.001)在儿科患者中很常见。总死亡率为30.7%,完全切除在幸存者中明显高于非幸存者(67.0% vs 30.8%; OR 0.218, 95% CI 0.097-0.492; p = 0.001)。没有头痛(p = 0.044)和部分切除手术(p = 0.001)与不良预后独立相关。我们描述了来自印度的CNS IMI患者的概要,突出了不同年龄组和真菌类型的不同临床模式和治疗结果。这就需要对该国的宿主和病原体相关因素进行调查。经费资助包括科学和技术部-科学和工程研究委员会(dst -塞族),印度新德里和印度医学研究理事会(ICMR),印度新德里。
{"title":"Invasive mould infections of the central nervous system in the Indian population: a cohort study (2004–2025)","authors":"Harsimran Kaur ,&nbsp;Shivaprakash M. Rudramurthy ,&nbsp;Rimjhim Kanaujia ,&nbsp;Haseen Ahmad ,&nbsp;Pravin Salunke ,&nbsp;Deepak Bansal ,&nbsp;Kirti Gupta ,&nbsp;Debajyoti Chatterjee ,&nbsp;Chirag Kamal Ahuja ,&nbsp;Aastha Takkar Kapila ,&nbsp;Manish Modi ,&nbsp;Sandeep Mohindra ,&nbsp;Rajesh Chhabra ,&nbsp;Madhivanan Karthigeyan ,&nbsp;Harpreet Singh ,&nbsp;Apinderpreet Singh ,&nbsp;Ashish Agarwal ,&nbsp;Sanjay Verma ,&nbsp;Sunil Kumar Gupta ,&nbsp;Sanjay Jain ,&nbsp;Arunaloke Chakrabarti","doi":"10.1016/j.lansea.2026.100736","DOIUrl":"10.1016/j.lansea.2026.100736","url":null,"abstract":"<div><h3>Background</h3><div>Central nervous system (CNS) invasive mould infection (IMI) is a rare but life-threatening condition. Limited large-scale studies hinder the understanding of its clinical characteristics and optimal management strategies.</div></div><div><h3>Methods</h3><div>This was a cohort study. We reviewed confirmed patients of CNS IMI (January 2004–March 2025) by microbiological (direct microscopy and/or culture) and/or histopathological evidence at our tertiary care hospital. Clinical, demographic and mycological characteristics were analysed and compared.</div></div><div><h3>Findings</h3><div>Among 1321 brain abscess/biopsy samples, 127 patients (9.6%) were of fungal origin (adults, 100; paediatrics, 27). The median age was 30 (IQR: 27) years, with male predominance (71.7%). Adults were significantly infected by melanized fungi (p = 0.003). Seventy-four percent of patients had no identifiable underlying immunocompromising condition. The median duration of symptoms was 15 days (IQR: 23 days), including headache (61.4%) and seizures (50.4%). Frequency of fever was significantly higher in infection by melanized fungi (p = 0.02). Frontal lobe involvement was common in paediatric age (OR 0.379, 95% CI 0.141–1.019; p = 0.05). <em>Aspergillus</em> spp. (56.3%) and <em>Cladophialophora bantiana</em> (21.36%) were the predominant pathogens. <em>Deniquelata barringtoniae</em> was reported as a human pathogen. Voriconazole (61.4%) and liposomal amphotericin B (28.3%) were the primary antifungals used. Surgical intervention was performed in all patients. Partial excision (66.7% vs 38.0%, OR 0.306, 95% CI 0.125–0.751; p = 0.01) and use of liposomal amphotericin B (55.6% vs 21%, OR 0.213, 95% CI 0.087–0.522 p = 0.001) were common in paediatric patients. The overall mortality was 30.7%, complete excision was significantly more frequent among survivors than non-survivors (67.0% vs 30.8%; OR 0.218, 95% CI 0.097–0.492; p = 0.001). Lack of headache (p = 0.044) and partial excision surgery (p = 0.001) were independently associated with poor outcome.</div></div><div><h3>Interpretation</h3><div>We describe a compendium of CNS IMI in patients from India, highlighting distinct clinical patterns and treatment outcomes across age groups and fungal types. This warrants investigation of host and pathogen-related factors in the country.</div></div><div><h3>Funding</h3><div>Funding included <span>Department of Science and Technology-Science and Engineering Research Board</span> (DST-SERB), New Delhi, India and <span>Indian Council of Medical Research</span> (ICMR), New Delhi, India.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"46 ","pages":"Article 100736"},"PeriodicalIF":6.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147424302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TB far from elimination: an enduring reality in the southeast Asia region 结核病远未消除:东南亚地区的一个持久现实
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/j.lansea.2026.100750
The Lancet Regional Health – Southeast Asia
{"title":"TB far from elimination: an enduring reality in the southeast Asia region","authors":"The Lancet Regional Health – Southeast Asia","doi":"10.1016/j.lansea.2026.100750","DOIUrl":"10.1016/j.lansea.2026.100750","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"46 ","pages":"Article 100750"},"PeriodicalIF":6.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147449623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Universal health coverage and priority diseases diagnostics: a case study of Essential Package of Health Services from Pakistan” “全民健康覆盖和重点疾病诊断:巴基斯坦一揽子基本保健服务案例研究”
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-01-19 DOI: 10.1016/j.lansea.2026.100719
Mohammad Zeeshan , Sadia Shakoor , Amna Rehana Siddiqui , Rumina Hasan
{"title":"“Universal health coverage and priority diseases diagnostics: a case study of Essential Package of Health Services from Pakistan”","authors":"Mohammad Zeeshan ,&nbsp;Sadia Shakoor ,&nbsp;Amna Rehana Siddiqui ,&nbsp;Rumina Hasan","doi":"10.1016/j.lansea.2026.100719","DOIUrl":"10.1016/j.lansea.2026.100719","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100719"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145993551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH–Rural India Study 无症状成人的亚临床冠状动脉粥样硬化负担:reach -印度农村研究
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-11 DOI: 10.1016/j.lansea.2026.100726
Avinash Kumar Raghupathy , Mohanraj Sundaresan , Pudhiavan Arun , Dharam J. Kumbhani , Manoj Kumar Baskar , Haritha Thambi , Parthasarathy Ayothi , Karthika Durairaj , Samrat Ashok Vasudevan , Srinidhi Narayani Seenivasan , Buvaneswari Gajendran , Gowdham Manivel , Gowri Subramaniam , Madhavi Sambandam , Velmurugan Ganesan , Balakumaran Jeyakumaran , Jeevithan Shanmugam , Krishnan Swaminathan , Arulraj Ramakrishnan , Mathew Cherian , Thomas Alexander

Background

Coronary artery calcification (CAC) serves as a robust marker of subclinical atherosclerosis and an independent predictor of cardiovascular disease (CVD). Despite its clinical significance, population-based evidence on CAC prevalence and its determinants in rural India remains limited. This study aimed to estimate the prevalence of CAC and evaluate its association with cardiometabolic risk factors among adults aged 35–65 years in a rural Indian population.

Methods

A total of 3006 individuals aged 35–65 years were selected and invited to participate in the REACH (Risk Evaluation of Subclinical Coronary Health)–Rural India Study. From 2022 to 2024, the study enrolled asymptomatic adults with no history of cardiovascular events from rural communities in the Coimbatore and Tirupur districts of Tamil Nadu, India. Data collection included sociodemographic and clinical profiling, laboratory testing, and carotid intima-media thickness (cIMT). CAC was quantified using the Agatston scoring method from dual-source CT scans.

Findings

In total 2961 participants included in the final analysis (mean age 49.8 ± 8.3 years; 52.8% women), the overall prevalence of coronary artery calcification (CAC) was 25.6%. Prevalence was significantly higher in men (33.5%) than in women (18.5%) (p < 0.001). The prevalence of severe CAC (Agatston score >400) was threefold higher in men and most common in those aged 56–65 years. However, no detectable CAC was observed among women aged 35–45 years. The distribution of CAC scores was as follows: 7.0% had minimal CAC (1–10), 11.4% mild (11–100), 5.2% moderate (101–400), and 1.9% severe (>400). Multivariable logistic regression showed that diabetes, hypertension, overweight/obesity, and abnormal CIMT were independently associated with CAC. Among men, current smoking was also significantly associated (OR = 1.51; 95% CI: 1.18–1.93). In total, 83.5% of individuals with CAC had one or more cardiovascular risk factors. No significant associations were observed between CAC and elevated creatinine, reduced eGFR and peripheral artery disease (PAD) after full adjustment.

Interpretation

This study reveals a substantial burden of CAC in a rural Indian population, with prevalence patterns comparable to urban cohorts in Western countries. The findings underscore the need to incorporate CAC screening in individuals with metabolic risk factors, especially in underserved populations, to identify early subclinical atherosclerosis and reduce CVD risk.

Funding

Indian Council of Medical Research (ICMR), (REF No. 5/4/1-9/2020-NCD-1).
背景:冠状动脉钙化(CAC)是亚临床动脉粥样硬化的有力标志,也是心血管疾病(CVD)的独立预测因子。尽管具有临床意义,但在印度农村,基于人群的CAC患病率及其决定因素的证据仍然有限。本研究旨在估计印度农村35-65岁成年人CAC的患病率,并评估其与心脏代谢危险因素的关系。方法:选择3006名年龄在35-65岁之间的人参加印度农村地区亚临床冠状动脉健康风险评估研究。从2022年到2024年,该研究招募了来自印度泰米尔纳德邦哥印拜陀和蒂鲁普尔地区农村社区无心血管事件史的无症状成年人。数据收集包括社会人口学和临床分析、实验室检测和颈动脉内膜-中膜厚度(cIMT)。采用双源CT扫描的Agatston评分法对CAC进行量化。结果:在最终分析的2961名参与者中(平均年龄49.8±8.3岁,女性占52.8%),冠状动脉钙化(CAC)的总患病率为25.6%。男性的患病率(33.5%)明显高于女性(18.5%)(p < 0.001)。严重CAC的患病率(Agatston评分为4400)在男性中高出三倍,最常见于56-65岁的人群。然而,在35-45岁的女性中未观察到可检测的CAC。CAC评分的分布如下:轻度CAC(1-10)占7.0%,轻度CAC(11-100)占11.4%,中度CAC(101-400)占5.2%,重度CAC (bb0 -400)占1.9%。多变量logistic回归显示,糖尿病、高血压、超重/肥胖和异常的CIMT与CAC独立相关。在男性中,目前吸烟也显著相关(OR = 1.51; 95% CI: 1.18-1.93)。总的来说,83.5%的CAC患者有一种或多种心血管危险因素。完全调整后,CAC与肌酐升高、eGFR降低和外周动脉疾病(PAD)之间无显著关联。解释:这项研究揭示了印度农村人口中CAC的巨大负担,其流行模式与西方国家的城市人群相当。研究结果强调了在具有代谢危险因素的个体中,特别是在服务不足的人群中,需要结合CAC筛查,以识别早期亚临床动脉粥样硬化并降低心血管疾病风险。资助:印度医学研究委员会(ICMR),(参考编号:5/4/1-9/2020-NCD-1)。
{"title":"Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH–Rural India Study","authors":"Avinash Kumar Raghupathy ,&nbsp;Mohanraj Sundaresan ,&nbsp;Pudhiavan Arun ,&nbsp;Dharam J. Kumbhani ,&nbsp;Manoj Kumar Baskar ,&nbsp;Haritha Thambi ,&nbsp;Parthasarathy Ayothi ,&nbsp;Karthika Durairaj ,&nbsp;Samrat Ashok Vasudevan ,&nbsp;Srinidhi Narayani Seenivasan ,&nbsp;Buvaneswari Gajendran ,&nbsp;Gowdham Manivel ,&nbsp;Gowri Subramaniam ,&nbsp;Madhavi Sambandam ,&nbsp;Velmurugan Ganesan ,&nbsp;Balakumaran Jeyakumaran ,&nbsp;Jeevithan Shanmugam ,&nbsp;Krishnan Swaminathan ,&nbsp;Arulraj Ramakrishnan ,&nbsp;Mathew Cherian ,&nbsp;Thomas Alexander","doi":"10.1016/j.lansea.2026.100726","DOIUrl":"10.1016/j.lansea.2026.100726","url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery calcification (CAC) serves as a robust marker of subclinical atherosclerosis and an independent predictor of cardiovascular disease (CVD). Despite its clinical significance, population-based evidence on CAC prevalence and its determinants in rural India remains limited. This study aimed to estimate the prevalence of CAC and evaluate its association with cardiometabolic risk factors among adults aged 35–65 years in a rural Indian population.</div></div><div><h3>Methods</h3><div>A total of 3006 individuals aged 35–65 years were selected and invited to participate in the REACH (Risk Evaluation of Subclinical Coronary Health)–Rural India Study. From 2022 to 2024, the study enrolled asymptomatic adults with no history of cardiovascular events from rural communities in the Coimbatore and Tirupur districts of Tamil Nadu, India. Data collection included sociodemographic and clinical profiling, laboratory testing, and carotid intima-media thickness (cIMT). CAC was quantified using the Agatston scoring method from dual-source CT scans.</div></div><div><h3>Findings</h3><div>In total 2961 participants included in the final analysis (mean age 49.8 ± 8.3 years; 52.8% women), the overall prevalence of coronary artery calcification (CAC) was 25.6%. Prevalence was significantly higher in men (33.5%) than in women (18.5%) (p &lt; 0.001). The prevalence of severe CAC (Agatston score &gt;400) was threefold higher in men and most common in those aged 56–65 years. However, no detectable CAC was observed among women aged 35–45 years. The distribution of CAC scores was as follows: 7.0% had minimal CAC (1–10), 11.4% mild (11–100), 5.2% moderate (101–400), and 1.9% severe (&gt;400). Multivariable logistic regression showed that diabetes, hypertension, overweight/obesity, and abnormal CIMT were independently associated with CAC. Among men, current smoking was also significantly associated (OR = 1.51; 95% CI: 1.18–1.93). In total, 83.5% of individuals with CAC had one or more cardiovascular risk factors. No significant associations were observed between CAC and elevated creatinine, reduced eGFR and peripheral artery disease (PAD) after full adjustment.</div></div><div><h3>Interpretation</h3><div>This study reveals a substantial burden of CAC in a rural Indian population, with prevalence patterns comparable to urban cohorts in Western countries. The findings underscore the need to incorporate CAC screening in individuals with metabolic risk factors, especially in underserved populations, to identify early subclinical atherosclerosis and reduce CVD risk.</div></div><div><h3>Funding</h3><div><span>Indian Council of Medical Research</span> (ICMR), (REF No. 5/4/1-9/2020-NCD-1).</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100726"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146230109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term sequelae and functional outcomes in the largest cohort of Nipah virus survivors in Bangladesh 孟加拉国最大的尼帕病毒幸存者队列的长期后遗症和功能结局。
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-11 DOI: 10.1016/j.lansea.2026.100729
Wasik Rahman Aquib , Utpal K. Mondal , Arifa Nazneen , Dewan Imtiaz Rahman , Shadman Sakib Choudhury , Tonmoy Sarkar , Smita Sarker , S.M. Zafor Shafique , Ariful Islam , Arifur Rahman Bablu , Muhammad Rashedul Alam , Faruq Abdulla , Nazrul Islam , Md. Kamal Hossain , Ayesha Siddika , Carolyn Clark , Vijay Zala , Neil Cherian , Kamal Ibne Amin Chowdhury , Sharmin Sultana , Syed Moinuddin Satter

Background

Since 2001, Bangladesh has experienced recurrent outbreaks of Nipah virus (NiV) infection. While acute-phase manifestations are well documented, long-term clinical and functional sequelae poorly characterized.

Methods

We conducted a cross-sectional assessment of 52 adult NiV survivors in Bangladesh between November 2021 and February 2022 to document the persistence, severity, and functional impact of post infection symptoms. Symptom history, clinical evaluation, and functional status were assessed using structured questionnaires and the Washington Group Extended Set on Functioning (WG-ES).

Findings

All the survivors reported fever during acute illness, with frequent symptoms including headache (71%), severe weakness (67%), and altered mental status (44%). Following recovery, survivors reported a wide range of symptoms including sleep disturbance (58%), gait disturbance (54%), chronic fatigue (52%), memory and concentration difficulties (54%) and myoclonus (48%). Neurological, musculoskeletal, and respiratory symptoms persisted with varying severity and chronicity. Functional assessments revealed notable disability in several domains, particularly anxiety (48%), mobility (31%), and cognition (25%). Although post-infection symptoms were common, 65% of survivors met criteria for disability in at least one functional domain, and 48% had disabilities across multiple domains.

Interpretation

These findings highlight the substantial and enduring burden experienced by NiV survivors in Bangladesh. The range and persistence of sequelae in this cohort appear broader than previously documented in Malaysia–Singapore survivor studies; however, methodological differences limit formal comparison. As the largest clinical and functional assessment of NiV survivors to date, this study provides essential evidence to inform long-term care strategies and underscores the need for survivor-focused rehabilitation and monitoring in outbreak-prone settings.

Funding

This study was supported by the Coalition for Epidemic Preparedness Innovations (CEPI) (Grant No: GR-02160). The funding body had no role in the study design; data collection, management, analysis, or interpretation; writing of the manuscript; or the decision to submit the manuscript for publication. The views and conclusions expressed in this manuscript are those of the authors and should not be construed as representing the official viewpoints of CEPI or the U.S. Centers for Disease Control and Prevention.
背景:自2001年以来,孟加拉国反复暴发尼帕病毒感染。虽然急性期的表现是有据可查的,但长期的临床和功能后遗症却没有明确的特征。方法:我们在2021年11月至2022年2月期间对孟加拉国的52名成年NiV幸存者进行了横断面评估,以记录感染后症状的持续性、严重程度和功能影响。采用结构化问卷和Washington Group功能扩展集(WG-ES)对症状史、临床评价和功能状态进行评估。结果:所有幸存者报告急性疾病期间发烧,并伴有常见症状,包括头痛(71%)、严重虚弱(67%)和精神状态改变(44%)。康复后,幸存者报告了各种各样的症状,包括睡眠障碍(58%)、步态障碍(54%)、慢性疲劳(52%)、记忆和注意力困难(54%)和肌阵挛(48%)。神经系统、肌肉骨骼和呼吸系统症状持续存在,其严重程度和慢性程度不同。功能评估显示在几个领域有明显的残疾,特别是焦虑(48%)、行动能力(31%)和认知能力(25%)。虽然感染后症状很常见,但65%的幸存者至少在一个功能领域符合残疾标准,48%的人在多个领域都有残疾。解释:这些发现突出了孟加拉国NiV幸存者所经历的巨大和持久的负担。在这个队列中,后遗症的范围和持久性似乎比先前在马来西亚-新加坡幸存者研究中记录的更广泛;然而,方法上的差异限制了正式的比较。作为迄今为止对NiV幸存者进行的最大规模的临床和功能评估,本研究为制定长期护理策略提供了重要证据,并强调了在易爆发环境中以幸存者为中心的康复和监测的必要性。资助:本研究得到流行病防范创新联盟(CEPI)的支持(批准号:GR-02160)。资助机构在研究设计中没有任何作用;数据收集、管理、分析或解释;稿件的撰写;或者决定提交稿件发表。本文中表达的观点和结论是作者的观点和结论,不应被解释为代表CEPI或美国疾病控制与预防中心的官方观点。
{"title":"Long-term sequelae and functional outcomes in the largest cohort of Nipah virus survivors in Bangladesh","authors":"Wasik Rahman Aquib ,&nbsp;Utpal K. Mondal ,&nbsp;Arifa Nazneen ,&nbsp;Dewan Imtiaz Rahman ,&nbsp;Shadman Sakib Choudhury ,&nbsp;Tonmoy Sarkar ,&nbsp;Smita Sarker ,&nbsp;S.M. Zafor Shafique ,&nbsp;Ariful Islam ,&nbsp;Arifur Rahman Bablu ,&nbsp;Muhammad Rashedul Alam ,&nbsp;Faruq Abdulla ,&nbsp;Nazrul Islam ,&nbsp;Md. Kamal Hossain ,&nbsp;Ayesha Siddika ,&nbsp;Carolyn Clark ,&nbsp;Vijay Zala ,&nbsp;Neil Cherian ,&nbsp;Kamal Ibne Amin Chowdhury ,&nbsp;Sharmin Sultana ,&nbsp;Syed Moinuddin Satter","doi":"10.1016/j.lansea.2026.100729","DOIUrl":"10.1016/j.lansea.2026.100729","url":null,"abstract":"<div><h3>Background</h3><div>Since 2001, Bangladesh has experienced recurrent outbreaks of Nipah virus (NiV) infection. While acute-phase manifestations are well documented, long-term clinical and functional sequelae poorly characterized.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional assessment of 52 adult NiV survivors in Bangladesh between November 2021 and February 2022 to document the persistence, severity, and functional impact of post infection symptoms. Symptom history, clinical evaluation, and functional status were assessed using structured questionnaires and the Washington Group Extended Set on Functioning (WG-ES).</div></div><div><h3>Findings</h3><div>All the survivors reported fever during acute illness, with frequent symptoms including headache (71%), severe weakness (67%), and altered mental status (44%). Following recovery, survivors reported a wide range of symptoms including sleep disturbance (58%), gait disturbance (54%), chronic fatigue (52%), memory and concentration difficulties (54%) and myoclonus (48%). Neurological, musculoskeletal, and respiratory symptoms persisted with varying severity and chronicity. Functional assessments revealed notable disability in several domains, particularly anxiety (48%), mobility (31%), and cognition (25%). Although post-infection symptoms were common, 65% of survivors met criteria for disability in at least one functional domain, and 48% had disabilities across multiple domains.</div></div><div><h3>Interpretation</h3><div>These findings highlight the substantial and enduring burden experienced by NiV survivors in Bangladesh. The range and persistence of sequelae in this cohort appear broader than previously documented in Malaysia–Singapore survivor studies; however, methodological differences limit formal comparison. As the largest clinical and functional assessment of NiV survivors to date, this study provides essential evidence to inform long-term care strategies and underscores the need for survivor-focused rehabilitation and monitoring in outbreak-prone settings.</div></div><div><h3>Funding</h3><div>This study was supported by the <span>Coalition for Epidemic Preparedness Innovations</span> (CEPI) (Grant No: <span><span>GR-02160</span></span>). The funding body had no role in the study design; data collection, management, analysis, or interpretation; writing of the manuscript; or the decision to submit the manuscript for publication. The views and conclusions expressed in this manuscript are those of the authors and should not be construed as representing the official viewpoints of CEPI or the U.S. Centers for Disease Control and Prevention.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100729"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146230066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MASLD: time to optimise regional research priorities MASLD:优化区域研究重点的时间。
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-19 DOI: 10.1016/j.lansea.2026.100732
The Lancet Regional Health – Southeast Asia
{"title":"MASLD: time to optimise regional research priorities","authors":"The Lancet Regional Health – Southeast Asia","doi":"10.1016/j.lansea.2026.100732","DOIUrl":"10.1016/j.lansea.2026.100732","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100732"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147313349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thank you to The Lancet Regional Health – Southeast Asia's clinical and statistical peer reviewers in 2025 感谢《柳叶刀区域卫生-东南亚》2025年的临床和统计同行审稿人
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-19 DOI: 10.1016/j.lansea.2026.100740
{"title":"Thank you to The Lancet Regional Health – Southeast Asia's clinical and statistical peer reviewers in 2025","authors":"","doi":"10.1016/j.lansea.2026.100740","DOIUrl":"10.1016/j.lansea.2026.100740","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100740"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147421422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of MASLD and liver fibrosis: evidence from Phenome India cohort MASLD的负担和肝纤维化:来自印度表型组的证据。
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-03 DOI: 10.1016/j.lansea.2026.100723
Meghana Arvind , Anshul Verma , Sreeshma Raj K , Satyartha Prakash , Vignesh S. Kumar , Mohammad Azhar Uddin , Ayushi Narayan , Mamta Rathore , Nancy Rawat , Ankita Sahu , Yogesh Kumar , Pulkit Hasmukhbhai Leuva , Monika Sharma , Rajesh S , Dwaipayan Saha , Ankita Mridha , Ishant Jyoti Nath , Ashique Hussain , Borsha Rajkumari , Mamta Thapa , Rashmi Arya

Background

Metabolic-dysfunction-associated steatotic liver disease (MASLD) is rising globally, including in India, yet community-based data remain scarce. We address this critical knowledge gap by assessing the prevalence, distribution, and characteristics of MASLD subgroups and fibrosis, leveraging the Phenome India cohort.

Methods

In this prospective study, we recruited 10,267 adults across 37 laboratories of the Council of Scientific and Industrial Research (CSIR) from 27 Indian cities. All permanent staff members of the CSIR, including current employees, retirees, and their spouses who responded to the recruitment campaign and provided voluntary consent, were considered for participation in the Phenome India Cohort. Steatosis and fibrosis were assessed using Transient Elastography, along with associated clinical, biochemical, cytokine and anthropometric data. Overall, crude and age-adjusted prevalence rates were estimated in the study population and various subgroups.

Findings

Of 10,267 individuals screened, 7764 were included, 3712 (47.8%) fulfilled MASLD criteria, corresponding to an age-adjusted prevalence of 38.9% (95% CI 37.2–40.6). Significant fibrosis, defined as liver stiffness measurement (LSM) ≥8.2 kPa (≥F2), was more frequent in MASLD (6.3% [234 of 3688]) than in cases without-MASLD (1.7% [69 of 4027]), corresponding to an age-adjusted prevalence of 4.1% in MASLD. Overall age-adjusted prevalence of significant fibrosis was 2.4%, which clustered in older adults (>60 years) and in those with diabetes or obesity class II, with evidence of possible regional variation.

Interpretation

MASLD affected over one-third of participants. Site-specific disparities were observed, which suggest the need for large-scale longitudinal studies to elucidate region-specific risk factors and temporal trends. Community-based awareness and targeted public health interventions across diverse geographical and socio-cultural settings in India may help curb the rising burden.

Funding

The work was funded by CSIR, India grant HCP47.
背景:代谢功能障碍相关的脂肪变性肝病(MASLD)在全球范围内呈上升趋势,包括在印度,但基于社区的数据仍然很少。我们利用Phenome India队列,通过评估MASLD亚组和纤维化的患病率、分布和特征来解决这一关键的知识差距。方法:在这项前瞻性研究中,我们从印度27个城市的科学与工业研究委员会(CSIR)的37个实验室招募了10267名成年人。CSIR的所有长期工作人员,包括响应招聘活动并提供自愿同意的在职员工、退休人员及其配偶,都被考虑参加Phenome印度队列。脂肪变性和纤维化的评估采用瞬时弹性成像,以及相关的临床、生化、细胞因子和人体测量数据。总体而言,在研究人群和各个亚组中估计了粗患病率和年龄调整患病率。结果:在10,267名筛查个体中,包括7764名,其中3712名(47.8%)符合MASLD标准,对应于年龄调整后的患病率为38.9% (95% CI 37.2-40.6)。显著纤维化,定义为肝硬度测量(LSM)≥8.2 kPa(≥F2), MASLD患者(6.3%[3688例中的234例])比非MASLD患者(1.7%[4027例中的69例])更常见,相当于MASLD的年龄调整患病率为4.1%。总体年龄调整后的显著纤维化患病率为2.4%,集中在老年人(60岁至60岁)和糖尿病或II级肥胖患者中,有证据表明可能存在区域差异。解释:MASLD影响了超过三分之一的参与者。观察到不同地点的差异,这表明需要进行大规模的纵向研究来阐明特定区域的风险因素和时间趋势。在印度,以社区为基础的认识和跨不同地理和社会文化背景的有针对性的公共卫生干预措施可能有助于遏制日益增加的负担。资助:本工作由CSIR,印度基金HCP47资助。
{"title":"Burden of MASLD and liver fibrosis: evidence from Phenome India cohort","authors":"Meghana Arvind ,&nbsp;Anshul Verma ,&nbsp;Sreeshma Raj K ,&nbsp;Satyartha Prakash ,&nbsp;Vignesh S. Kumar ,&nbsp;Mohammad Azhar Uddin ,&nbsp;Ayushi Narayan ,&nbsp;Mamta Rathore ,&nbsp;Nancy Rawat ,&nbsp;Ankita Sahu ,&nbsp;Yogesh Kumar ,&nbsp;Pulkit Hasmukhbhai Leuva ,&nbsp;Monika Sharma ,&nbsp;Rajesh S ,&nbsp;Dwaipayan Saha ,&nbsp;Ankita Mridha ,&nbsp;Ishant Jyoti Nath ,&nbsp;Ashique Hussain ,&nbsp;Borsha Rajkumari ,&nbsp;Mamta Thapa ,&nbsp;Rashmi Arya","doi":"10.1016/j.lansea.2026.100723","DOIUrl":"10.1016/j.lansea.2026.100723","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic-dysfunction-associated steatotic liver disease (MASLD) is rising globally, including in India, yet community-based data remain scarce. We address this critical knowledge gap by assessing the prevalence, distribution, and characteristics of MASLD subgroups and fibrosis, leveraging the Phenome India cohort.</div></div><div><h3>Methods</h3><div>In this prospective study, we recruited 10,267 adults across 37 laboratories of the Council of Scientific and Industrial Research (CSIR) from 27 Indian cities. All permanent staff members of the CSIR, including current employees, retirees, and their spouses who responded to the recruitment campaign and provided voluntary consent, were considered for participation in the Phenome India Cohort. Steatosis and fibrosis were assessed using Transient Elastography, along with associated clinical, biochemical, cytokine and anthropometric data. Overall, crude and age-adjusted prevalence rates were estimated in the study population and various subgroups.</div></div><div><h3>Findings</h3><div>Of 10,267 individuals screened, 7764 were included, 3712 (47.8%) fulfilled MASLD criteria, corresponding to an age-adjusted prevalence of 38.9% (95% CI 37.2–40.6). Significant fibrosis, defined as liver stiffness measurement (LSM) ≥8.2 kPa (≥F2), was more frequent in MASLD (6.3% [234 of 3688]) than in cases without-MASLD (1.7% [69 of 4027]), corresponding to an age-adjusted prevalence of 4.1% in MASLD. Overall age-adjusted prevalence of significant fibrosis was 2.4%, which clustered in older adults (&gt;60 years) and in those with diabetes or obesity class II, with evidence of possible regional variation.</div></div><div><h3>Interpretation</h3><div>MASLD affected over one-third of participants. Site-specific disparities were observed, which suggest the need for large-scale longitudinal studies to elucidate region-specific risk factors and temporal trends. Community-based awareness and targeted public health interventions across diverse geographical and socio-cultural settings in India may help curb the rising burden.</div></div><div><h3>Funding</h3><div>The work was funded by <span>CSIR, India</span> grant HCP47.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100723"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ““Miles to go before I seek”: distance to the health facility and health care use among older adults in India” [The Lancet Regional Health Southeast Asia. Volume 37, 100579, April 2025] “在我寻求之前还有很长的路要走”:印度老年人到卫生设施的距离和卫生保健的使用”[《柳叶刀》东南亚区域卫生杂志]的更正。卷37,100579,四月2025]。
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-12-23 DOI: 10.1016/j.lansea.2025.100702
Sheuli Misra , Jeetendra Yadav , Abhinav Sinha , Krushna Chandra Sahoo , Shweta Tanwar , Sneh Shalini , Arohi Chauhan , Sanghamitra Pati
{"title":"Corrigendum to ““Miles to go before I seek”: distance to the health facility and health care use among older adults in India” [The Lancet Regional Health Southeast Asia. Volume 37, 100579, April 2025]","authors":"Sheuli Misra ,&nbsp;Jeetendra Yadav ,&nbsp;Abhinav Sinha ,&nbsp;Krushna Chandra Sahoo ,&nbsp;Shweta Tanwar ,&nbsp;Sneh Shalini ,&nbsp;Arohi Chauhan ,&nbsp;Sanghamitra Pati","doi":"10.1016/j.lansea.2025.100702","DOIUrl":"10.1016/j.lansea.2025.100702","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100702"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance and utility of contact tracing for COVID-19 in the WHO South-East Asia Region: implications for future pandemic preparedness 世卫组织东南亚区域COVID-19接触者追踪的绩效和效用:对未来大流行防范的影响
IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-02-10 DOI: 10.1016/j.lansea.2026.100728
Melanie Bannister-Tyrrell , Kirsty Teague , Daniel Ll Strachan , Anna Barrett , Tiara Marthias , Clare E. Strachan , Pawinee Doungngern , Nishant Thakur , Mushtofa Kamal , Hannah Brindle , Yuka Jinnai , Masaya Kato , Florian Vogt
Contact tracing was widely implemented during the COVID-19 pandemic, but its real-world performance and utility for decision-making remain poorly understood. A qualitative study was conducted to appraise the performance and utility of contact tracing for COVID-19 in the WHO South-East Asia Region, based on interviews with government and non-governmental organisation technical staff and decision makers in Indonesia, Nepal and Thailand. Our findings highlight the good performance of contact tracing when sufficiently resourced and when case load is low, but reveal declining utility as case incidence increases. This study presents key definitions and a pragmatic approach for appraising contact tracing performance and utility throughout a major health emergency response. Countries should prospectively define objectives for contact tracing, establish monitoring and evaluation frameworks, adjust their contact tracing approaches informed by risk assessments, and consider other available public health interventions when its performance and utility decline.

Funding

Governments of Germany and Australia.
在2019冠状病毒病大流行期间,接触者追踪得到了广泛实施,但其在现实世界中的表现和对决策的效用仍然知之甚少。根据对印度尼西亚、尼泊尔和泰国政府和非政府组织技术人员和决策者的访谈,开展了一项定性研究,以评估世卫组织东南亚区域COVID-19接触者追踪的效果和效用。我们的研究结果强调,当资源充足和病例负荷较低时,接触者追踪的效果良好,但随着病例发生率的增加,效用也在下降。本研究提出了评估接触者追踪绩效和整个重大卫生应急反应效用的关键定义和实用方法。各国应前瞻性地确定接触者追踪目标,建立监测和评价框架,根据风险评估调整其接触者追踪方法,并在其效果和效用下降时考虑其他可用的公共卫生干预措施。资助:德国和澳大利亚政府。
{"title":"Performance and utility of contact tracing for COVID-19 in the WHO South-East Asia Region: implications for future pandemic preparedness","authors":"Melanie Bannister-Tyrrell ,&nbsp;Kirsty Teague ,&nbsp;Daniel Ll Strachan ,&nbsp;Anna Barrett ,&nbsp;Tiara Marthias ,&nbsp;Clare E. Strachan ,&nbsp;Pawinee Doungngern ,&nbsp;Nishant Thakur ,&nbsp;Mushtofa Kamal ,&nbsp;Hannah Brindle ,&nbsp;Yuka Jinnai ,&nbsp;Masaya Kato ,&nbsp;Florian Vogt","doi":"10.1016/j.lansea.2026.100728","DOIUrl":"10.1016/j.lansea.2026.100728","url":null,"abstract":"<div><div>Contact tracing was widely implemented during the COVID-19 pandemic, but its real-world performance and utility for decision-making remain poorly understood. A qualitative study was conducted to appraise the performance and utility of contact tracing for COVID-19 in the WHO South-East Asia Region, based on interviews with government and non-governmental organisation technical staff and decision makers in Indonesia, Nepal and Thailand. Our findings highlight the good performance of contact tracing when sufficiently resourced and when case load is low, but reveal declining utility as case incidence increases. This study presents key definitions and a pragmatic approach for appraising contact tracing performance and utility throughout a major health emergency response. Countries should prospectively define objectives for contact tracing, establish monitoring and evaluation frameworks, adjust their contact tracing approaches informed by risk assessments, and consider other available public health interventions when its performance and utility decline.</div></div><div><h3>Funding</h3><div><span>Governments of Germany and Australia</span>.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"45 ","pages":"Article 100728"},"PeriodicalIF":6.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146230018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet regional health. Southeast Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1